Cargando…
Interference With the AMPKα/mTOR/NLRP3 Signaling and the IL-23/IL-17 Axis Effectively Protects Against the Dextran Sulfate Sodium Intoxication in Rats: A New Paradigm in Empagliflozin and Metformin Reprofiling for the Management of Ulcerative Colitis
Empagliflozin and metformin are widely used for the treatment of type 2 diabetes. These drugs showed marked anti-inflammatory effects in different animal models via enhancing AMPK activity. Yet, the protective anti-inflammatory effects of their combination against ulcerative colitis have not been pr...
Autores principales: | Youssef, Mahmoud E., Abd El-Fattah, Eslam E., Abdelhamid, Amir M., Eissa, Hanan, El-Ahwany, Eman, Amin, Noha A., Hetta, Helal F., Mahmoud, Mohamed H., Batiha, Gaber El-Saber, Gobba, Naglaa, Ahmed Gaafar, Ahmed Gaafar, Saber, Sameh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417441/ https://www.ncbi.nlm.nih.gov/pubmed/34489707 http://dx.doi.org/10.3389/fphar.2021.719984 |
Ejemplares similares
-
AKT-AMPKα-mTOR-dependent HIF-1α Activation is a New Therapeutic Target for Cancer Treatment: A Novel Approach to Repositioning the Antidiabetic Drug Sitagliptin for the Management of Hepatocellular Carcinoma
por: Abd El-Fattah, Eslam E., et al.
Publicado: (2022) -
Cytotoxic Chemotherapy as an Alternative for Systemic Treatment of Advanced Hepatocellular Carcinoma in Developing Countries
por: Abouelezz, Khaled, et al.
Publicado: (2020) -
Recent updates in COVID-19 with emphasis on inhalation therapeutics: Nanostructured and targeting systems
por: Abdellatif, Ahmed A.H., et al.
Publicado: (2021) -
A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition
por: Saber, Sameh, et al.
Publicado: (2021) -
Liver Protective Effects of Renin-Angiotensin System Inhibition Have No Survival Benefits in Hepatocellular Carcinoma Induced By Repetitive Administration of Diethylnitrosamine in Mice
por: Saber, Sameh, et al.
Publicado: (2018)